In this study, we examined associations between levels of
sESAM and cardiovascular outcomes in patients with stable
ischemic heart disease in order to study possible biological mechanisms
in a clinical population. Higher levels of sESAM were associated
with increased rates of the composite primary endpoint
(myocardial infarctions, heart failure hospitalizations, and death) as